Medical News Today -- Hormone replacement therapy (HRT) using oestrogen and progestin increases the risk of death from lung cancer. This finding should be incorporated into risk-benefit discussions for women considering HRT, especially those at high risk of lung cancer. These are the conclusions of an Article published Online First and in an upcoming edition of The Lancet, written by Professor Rowan Chlebowski, Los Angeles Biomedical Research Institute at Harbour-UCLA Medical Center, Torrance, CA, USA, and colleagues.
